Daiki Murata
Saga, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.
Journal: International journal of clinical oncology
Published: April 21, 2026
Biofabrication strategies for engineered constructs in cardiovascular tissue repair.
Journal: Regenerative therapy
Published: October 26, 2025
Response to the letter to the editor regarding "Bio-3D printing of scaffold-free ADSC-derived cartilage constructs comparable to natural cartilage in vitro".
Journal: Journal of orthopaedic surgery and research
Published: September 22, 2025
Challenges and opportunities in generating microvasculature using bioprinting techniques.
Journal: npj biomedical innovations
Published: August 30, 2025
Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: August 21, 2025
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression.
Journal: Anticancer research
Published: July 08, 2025
A scaffold-free cartilage construct fabricated using a bio 3D printer accelerates critical-size bone defect regeneration.
Journal: Journal of orthopaedic translation
Published: June 26, 2025
Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer.
Journal: BMC cancer
Published: June 23, 2025
Immune checkpoint inhibitor-induced interstitial lung disease with and without CTLA-4 regimen in non-small cell lung cancer patients and PD-L1 < 1 %: A multicenter, retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 26, 2025
Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab.
Journal: Translational lung cancer research
Published: May 13, 2025
Impact of stratifin/14-3-3σ on survival and interstitial lung disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
Journal: Cancer immunology, immunotherapy : CII
Published: March 27, 2025
Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.
Journal: Cancer research communications
Published: March 19, 2025
Last Updated: 09/26/2026